Zepbound on Good Hang with Amy Poehler

Nick Offerman

0:36
mid-roll
Amy Poehler
The Ringer
April 21, 2026
UnknownBrand awarenessBaked-in adHealthcare
0:00 / 0:36
@ 35:22 in ep

Estimated current placement value

Low confidence
~$12,000range $1,200$110,000

What a comparable one-episode placement on this show might cost today—not reported advertiser spend or a historical invoice.

How this estimate works

A broad audience range for the top 10 popularity tier is multiplied by public CPM benchmarks and a placement factor. Inputs for this read: 0:36 · Unknown · mid-roll.

Model placement-value-v1-2026-08 · benchmark inputs as of 2026-08
Methodology and limitations →

Transcript

Snoring? Gasping during sleep? Feeling fatigued? Ask your doctor about Zepbound, tirzepatite, the first and only FDA approved prescription medicine for moderate to severe obstructive sleep apnea, OSA, in adults with obesity. Zepbound is a prescription medicine used with a reduced calorie diet and increased physical activity to help adults with moderate to severe sleep apnea, OSA, and obesity to improve their OSA. ZepBound is approved as a two point five, five, seven point five, ten, twelve point five, or fifteen milligram injection.

Auto-transcribed · verbatim audio matches · Report an error

Episode

Good Hang with Amy Poehler
Nick Offerman
Host: Amy Poehler
Publisher: The Ringer